Pembrolizumab related Guillain barre syndrome, a rare presentation in a patient with a history of lupus and bladder cancer

Pembrolizumab related Guillain barre syndrome, a rare presentation in a patient with a history of lupus and bladder cancer

Immune checkpoint inhibitor-related neurotoxicity causing Guillain Barre Syndrome is relatively uncommon. We discussed an 80-year-old patient with known systemic lupus erythematosus who presented with lower extremity weakness, areflexia and then progressed to respiratory muscle and upper extremity w...

Full description

Bibliographic Details
Main Authors: Vikram Sangani, Mytri Pokal, Mamtha Balla, Ganesh Prasad Merugu, Sreedhar Adapa, Srikanth Naramala, Venu Madhav Konala
Format: Article
Language:English
Published: Taylor & Francis Group 2021-05-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
keytruda
pembrolizumab
guillain barre syndrome
immune checkpoint inhibitor
neurological complications
pd 1 antibody
Online Access:http://dx.doi.org/10.1080/20009666.2021.1903133

Internet

http://dx.doi.org/10.1080/20009666.2021.1903133

Similar Items